The peptide neuromedin U (NMU) is elevated in NYHA II and III heart failure.
Vincent HealyTherese Ruane O'HoraFarouk Markos
Published in: ESC heart failure (2024)
NMU is elevated in serum from stage II and III heart failure patients, supporting data from our pre-heart failure animal model; however, further study is needed to determine whether NMU is a reliable biomarker for pre-heart failure.